Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity
E. V. Svirshchevskaya(Institute of Bioorganic Chemistry), Lyuba Varticovski(National Cancer Institute)
Cited by 23
Related Papers
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
|Breast Cancer Research|2008|660
HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair
|Molecular Cancer Therapeutics|2008|82